Simultaneous Heart-Kidney Transplantation for Ebstein's Anomaly: A Viable Treatment Option in Latin America

Edgar García-Cruz1, Andrea Luna-Hernández1, Jesús Alberto Blanco-Hernández2

  • 1Adult Congenital Heart Disease Clinic Instituto Nacional de Cardiología Ignacio Chávez Mexico City Mexico.

Clinical Case Reports
|August 9, 2026
PubMed

Insights

Simultaneous heart-kidney transplantation offers a life-saving option for patients with severe congenital heart disease and chronic kidney disease. This combined approach effectively addresses combined survival threats.

Area of Science:

  • Cardiology
  • Nephrology
  • Transplantation Surgery

Background:

  • Congenital heart disease (CHD) and advanced chronic kidney disease (CKD) significantly impact patient survival.
  • Patients with both severe CHD and CKD face complex medical challenges and limited treatment options.

Purpose of the Study:

  • To evaluate the efficacy and viability of simultaneous heart-kidney transplantation.
  • To assess this procedure as a treatment for patients with concurrent life-threatening CHD and CKD.

Main Methods:

  • Retrospective analysis of patient data undergoing simultaneous heart-kidney transplantation.
  • Evaluation of survival rates, graft function, and complication profiles post-transplantation.

Main Results:

  • Simultaneous heart-kidney transplantation demonstrated a viable and effective treatment outcome.
  • The procedure successfully addressed the dual threats to survival posed by severe CHD and advanced CKD.

Conclusions:

  • Simultaneous heart-kidney transplantation is a feasible and beneficial therapeutic strategy.
  • This combined organ transplant approach offers a critical solution for select patients with combined cardiac and renal failure.